Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis
Open Access
- 2 February 2023
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (3) , 1206
Abstract
Fecal calprotectin (FC) levels correlate with the disease activity of inflammatory bowel diseases (IBD); however, the utility of FC in predicting IBD relapse remains to be determined. We aim to evaluate the efficacy of fecal calprotectin in predicting the relapse of inflammatory bowel disease. We searched Pubmed (MEDLINE), Embase, Web of Science, and the Cochrane library databases up to 7 July 2021. Our study estimated the pooled sensitivity and specificity, summary receiver operating characteristic (SROC) curve, and the optimal cut-off value for predicting IBD relapse using a multiple threshold model. A total of 24 prospective studies were included in the meta-analysis. The optimal FC cut-off value was 152 μg/g. The pooled sensitivity and specificity of FC was 0.720 (0.528 to 0.856) and 0.740 (0.618 to 0.834), respectively. FC is a useful, non-invasive, and inexpensive biomarker for the early prediction of IBD relapse. An FC value of 152 μg/g is an ideal threshold to identify patients with a high relapse probability.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province of China (BK20181492, ZDXKB2016005)
- National Key Clinical Department of Laboratory Medicine of China in Nanjing (BK20181492, ZDXKB2016005)
- Key laboratory for Laboratory Medicine of Jiangsu Province (BK20181492, ZDXKB2016005)
- Priority Academic Program Development of Jiangsu Higher Education Institutions (BK20181492, ZDXKB2016005)
This publication has 67 references indexed in Scilit:
- Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn’s disease after ileocolonic resection: A prospective pilot studyUnited European Gastroenterology Journal, 2013
- Fecal Calprotectin Levels Predict the Clinical Course in Patients With New Onset of Ulcerative ColitisInflammatory Bowel Diseases, 2013
- Crohn's diseaseThe Lancet, 2012
- Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studiesInflammatory Bowel Diseases, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Prediction of Crohn’s disease relapse with faecal calprotectin in infliximab responders: a prospective studyAlimentary Pharmacology & Therapeutics, 2011
- Summary ROC curve based on a weighted Youden index for selecting an optimal cutpoint in meta‐analysis of diagnostic accuracyStatistics in Medicine, 2010
- Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective studyEuropean Journal of Gastroenterology & Hepatology, 2010
- Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapseInflammatory Bowel Diseases, 2009
- Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s diseaseGut, 2005